Meeting
Abstract Number: 115
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Intravenous low-molecular weight iron dextran is indicated for patients with iron deficiency who are unable to take oral iron or experience insufficient efficacy with oral replacement. Adverse effects have been reported, including anaphylaxis and death. The primary purpose of this study was to determine the proportion of patients experiencing adverse reactions in a wide […]
Abstract Number: 200
Hospital Medicine 2020, Virtual Competition
Background: Intravenous (IV) low molecular weight iron dextran is a safe and effective treatment for iron deficiency anemia (1). However, oral (PO) iron supplementation remains a preferred mode of iron repletion due to low cost and ease of administration. Unfortunately, the efficacy of PO iron varies due to differences in drug absorption and patient adherence. […]